|Year : 2017 | Volume
| Issue : 2 | Page : 97-104
|Patient-perceived barriers to lifestyle interventions in cirrhosis
Michael Ney1, Leah Gramlich2, Vanessa Mathiesen3, Robert J Bailey2, Mark Haykowsky4, Mang Ma1, Juan G Abraldes5, Puneeta Tandon5
1 Department of Medicine; The Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR), University of Alberta, Edmonton, Alberta, Canada
2 Department of Medicine; The Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR), University of Alberta; Department of Medicine, Royal Alexandra Hospital, Edmonton, Alberta, Canada
3 The Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR), University of Alberta; Alberta Health Services; Cirrhosis Care Clinic (Liver Unit), University of Alberta Hospital, Alberta, Canada
4 Division of Gastroenterology, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, Texas, USA
5 Department of Medicine; The Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR), University of Alberta; Cirrhosis Care Clinic (Liver Unit), University of Alberta Hospital, Edmonton, Alberta, Canada
Click here for correspondence address and email
|Date of Submission||05-May-2016|
|Date of Acceptance||21-Oct-2017|
|Date of Web Publication||29-Mar-2017|
| Abstract|| |
Background/Aims: Sarcopenia, muscle weakness, and physical frailty are independent predictors of mortality in cirrhosis. These adverse prognostic factors are potentially modifiable with lifestyle interventions, including adequate nutritional intake and physical activity. Our aim was to identify patient-perceived barriers and enablers to these interventions. Patients and Methods: Adult patients with cirrhosis were prospectively recruited from two tertiary care liver clinics. Patients were excluded if they had hepatocellular carcinoma beyond transplant criteria, other active malignancy, or advanced chronic disease. Results: A total of 127 patients (mean age: 60 ± 9 years, 58% males, and 48% with Child-Pugh-B/C (CP-B/C) disease) were included. Two-thirds of the patients had cirrhosis related to alcohol or hepatitis C. CP-B/C patients were more likely to take oral nutritional supplements (56% vs 29%) and less likely to consume animal protein daily (66% vs 85%) when compared to CP-A patients. Early satiety, altered taste, and difficulty in buying/preparing meals were more common in CP-B/C patients and even present in 20–30% of CP-A patients. Most patients reported adequate funds to purchase food. As quantified by the International Physical Activity Questionnaire-Short Form, 47% reported low activity levels, with no significant differences between groups. CP-B/C patients were more fatigued with exercise, however, overall Exercise Benefits/Barriers Scale scores were similar across groups. Conclusions: Barriers to nutritional intake and physical activity are common in cirrhosis and should be evaluated and treated in all patients. Asking simple screening questions in clinic and referring at-risk patients to expert multidisciplinary providers is a reasonable strategy to address these barriers. Future research should evaluate techniques to overcome modifiable barriers and enhance enablers.
Keywords: Exercise, fatigue, liver diseases, motor activity, nutrition therapy, surveys and questionnaires
|How to cite this article:|
Ney M, Gramlich L, Mathiesen V, Bailey RJ, Haykowsky M, Ma M, Abraldes JG, Tandon P. Patient-perceived barriers to lifestyle interventions in cirrhosis. Saudi J Gastroenterol 2017;23:97-104
|How to cite this URL:|
Ney M, Gramlich L, Mathiesen V, Bailey RJ, Haykowsky M, Ma M, Abraldes JG, Tandon P. Patient-perceived barriers to lifestyle interventions in cirrhosis. Saudi J Gastroenterol [serial online] 2017 [cited 2020 Apr 1];23:97-104. Available from: http://www.saudijgastro.com/text.asp?2017/23/2/97/203357
Liver cirrhosis is a chronic disease characterized by diffuse nodular hepatic fibrosis, portal hypertension, and progressive hepatic dysfunction. Although worldwide prevalence numbers are unknown, estimates of up to 1% have been proposed for histological cirrhosis, the most common etiologies of which are alcohol, nonalcoholic fatty liver disease, and viral hepatitis. In addition to damage to the involved organ, there are important extrahepatic consequences of cirrhosis, including significant reductions in muscle mass, muscle function, and exercise tolerance. These muscle-related deteriorations are not only prevalent  but have also gained attention as being robust, independent, and perhaps most importantly, potentially modifiable predictors of morbidity and mortality in cirrhosis.,
In noncirrhotic healthy and clinical populations, nutritional therapy and regular physical activity have been associated with important health and survival benefits., In patients with cirrhosis, there are fewer high-quality data available. Existing studies do, however, supports the association between nutritional therapy and significant improvements in muscle mass., Data is also accumulating that support the benefits of exercise in patients with cirrhosis. In a recent randomized controlled pilot trial of an 8-week supervised endurance training program, the exercise group was associated with significant improvements in peak oxygen uptake, muscle mass, and quality of life as well as significant reductions in fatigue as compared to a control group receiving usual care. These benefits have been reproduced in additional studies.,
The existing literature suggests that nutrition and exercise hold promise as safe and effective interventions in cirrhosis, with the potential to impact both morbidity and mortality. To optimize the uptake of these nonpharmacological “lifestyle” based interventions, we targeted the second step outlined in the Theoretical Domains Framework for behaviour change. The four steps outlined by the framework include determining the problem to be solved, identifying the barriers and enablers to be addressed, describing interventions to overcome barriers and enhance enablers, and, finally, measuring and understanding the impact of such interventions. Accordingly, in a cohort of outpatients with cirrhosis, we address steps one and two of the framework where we describe the self-reported nutritional intake and physical activity level of these patients and identify their perceived barriers and enablers to achieving adequate nutrition and exercise across Child-Pugh (CP) classes. This is an essential step prior to describing and understanding the impact of interventions.
| Patients and Methods|| |
This prospective study was conducted between August 2012 to February 2015 (with a 1-year hiatus in recruitment due to lack of research staff). Consecutive eligible outpatients with cirrhosis were recruited from two tertiary care liver clinics in Edmonton, Alberta, Canada. Inclusion criteria were a previous diagnosis of liver cirrhosis made by clinical, laboratory, radiology, or histology methods and age ≥18 years. Exclusion criteria were hepatocellular carcinoma beyond transplant listing criteria, other active malignancy, chronic obstructive pulmonary disease requiring home oxygen, chronic kidney disease requiring dialysis, and congestive heart failure with ejection fraction <50%. Local ethics approval was obtained prior to patient recruitment. As part of their outpatient liver care, over 90% of the patients had access to a registered dietician. However, neither physiotherapy or exercise counselling was included as part of routine clinical care.
General descriptive and socioeconomic data were collected from all patients. Dietary practices were characterized with a Food Frequency Questionnaire (FFQ). Barriers and enablers to nutritional intake were assessed with a nutritional barriers and enablers questionnaire. The International Physical Activity Questionnaire-Short Form (IPAQ-SF) was used to quantify physical activity. Data were reported as low versus moderate/high activity. Barriers and enablers to physical activity were assessed using the Exercise Benefits/Barriers Scale (EBBS). A detailed description of the surveys and their interpretation is found in the supplementary methods.
Demographic data were described using means and standard deviations (SD), medians, and interquartile ranges (IQR) or proportions. All baseline and survey data were presented for the group as a whole as well as subdivided into patients with CP-A cirrhosis versus those with CP-B/C disease. CP-B/C patients were grouped together because these patients frequently have decompensated liver disease and are distinguished from CP-A patients who are classified as clinically compensated. A t-test or Chi-square test was used to make comparisons between CP-A vs CP-B/C patients. A P value of <0.05 was considered statistically significant. All statistical analyses were performed with the Statistical Package for the Social Sciences version 22 statistical software (SPSS, Inc., Chicago, IL).
| Results|| |
A total of 140 eligible patients were invited to participate, and 127 patients consented and completed the study. The mean age of the study group was 60 ± 9 years, 58% were men, 90% were of Caucasian ethnicity, nearly half were married, and 52% were diagnosed with CP-A [Table 1]. Almost half of the patients had completed high school and 28% were employed at the time of the survey administration. The most common disease etiologies were alcohol (35%), hepatitis C (27%), and nonalcohol NASH/cryptogenic (21%). The proportion of CP-A patients did not differ significantly across liver disease etiologies. Significant differences were found between CP-A and CP-B/C patients for measures of disease severity, however, other baseline characteristics were similar between groups.
Dietary intake patterns
The food frequency questionnaire revealed a mean of 2.7 ± 0.9 meals per day, which was not significantly different across CP classes. CP-B/C patients consumed more snacks per day (2.5 ± 1.4 vs. 1.8 ± 1.1, P = 0.004), were more likely to take oral nutritional supplements (ONS) such as Ensure or Boost (56% vs. 29%, P = 0.002), and were less likely to consume meat-based protein on a daily basis (66% vs. 85%, P = 0.01) when compared to CP-A patients. The consumption of foods from the other food groups were similar between groups [Table 2]. It was common for patients of all disease severities to take vitamins and minerals (84%).
|Table 2: Selected Food Frequency Questionnaire responses in CP-A versus CP-B/C patients|
Click here to view
Barriers and enablers to nutrition
Barriers to nutritional intake were present even in CP-A patients. Only 77% of CP-A patients could finish an entire meal and 68% reported a good appetite [Table 3]. All barriers were more common in patients with advanced cirrhosis. The most common symptomatic barriers in the CP-B/C groups were low energy (46%), pain/illness (34%), nausea/vomiting (34%), and ascites (31%). Only 56% of those in the CP-B/C group had a good appetite and 53% could eat an entire meal. CP-B/C patients were less likely to report that “food tastes good” (61% vs. 80%, P = 0.02). Food access was more of a struggle for CP-B/C patients reporting that it was significantly more challenging to purchase food (31% vs. 14%, P = 0.02), travel to grocery stores, and prepare meals (46% versus 26%, P = 0.02). Patients without a spouse (n = 54) were at higher risk for each of these food access barriers (data not shown).
With regard to enablers to nutritional intake, almost 90% of all patients reported that they were comfortable reading nutrition labels on food packaging, restricting dietary salt intake, and having enough money to purchase food.
Physical activity status
Only 15% of patients reported performing any vigorous physical activity for any duration. Moderate physical activities were reported by 34% of patients and 77% reported walking >10 minutes per day. Total combined patient activity was measured in metabolic equivalent of task (MET)-minutes/week with a median level of 693 (IQR: 1748). One MET is equal to energy expenditure of sitting quietly at rest. Less than 600 MET-minutes per week is considered a “low” physical activity level. When stratified according to the IPAQ scoring guide, 47%, 38%, and 15% of patients had low, moderate, and high activity levels, respectively. The mean MELD score in the low activity group was 13 ± 5.7 compared to 11.2 ± 4.9 (P = 0.06) when the moderate and high activity groups were combined [Figure 1].
|Figure 1: Mean Exercise Benefits/Barriers Scale (EBBS) score and model for end-stage liver disease (MELD) score stratified by activity level. Higher activity levels were associated with greater EBBS scores|
Click here to view
Barriers and enablers to physical activity
Perceived barriers and enablers to exercise are presented in [Table 4] (also [Supplementary Table 1 [Additional file 1]]). When the mean scores of barriers were compared, two were prevalent for CP-B/C vs CP-A patients – “Exercise tires me” (P = 0.04) and “I am fatigued by exercise” (P = 0.002).
|Table 4: Selected questions from EBBS reported as mean±SD scores or percentage of patients responding either agree/strongly agree with comparison P values|
Click here to view
On the enablers side, the majority of patients reported that they agreed or strongly agreed with the health-benefits of exercise, including its effects on muscle strength and function, protection against cardiovascular disease, improved disposition, and mental alertness. The only significant difference was that less CP-B/C patients reported improved feelings of well-being from exercise (79% versus 92%, P = 0.03). Only 2% of the patients felt that exercise took too much time from their family responsibilities and exercise was too costly for only 9% of patients. The cumulative scores for both the benefits and barriers scales were nearly identical between CP-A and CP-B/C patients. Patients in the low activity group had a lower combined EBBS score than patients in the moderate/high activity group, P = 0.008 [Figure 1], suggesting a more positive attitude toward exercise in the moderate/high activity group.
| Discussion|| |
This prospective study is the first to address the benefits and barriers of lifestyle interventions in cirrhosis. The main study findings are threefold. First, although the majority of patients consume foods from each food group, concordant with the published literature, patients with CP-B/C cirrhosis are less likely to consume meat-based protein on a daily basis than CP-A patients. Second, significant and potentially modifiable barriers exist to nutritional intake in cirrhosis, notable even in those patients with CP-A disease, but most marked in patients with CP-B/C disease. Third, although EBBS scores are similar to those reported for the general population, self-reported physical activity levels in patients with cirrhosis are low, with fatigue noted as the major barrier.
Since it is probable that many barriers to nutritional intake may be lessened by routine access to a dietician, we chose to focus on a cohort of patients in which the majority had received dietary counselling. This allowed us to determine the barriers that remained despite counselling. In accordance with this education, 90% of our patients reported a high level of comfort with label reading and 84% reported taking vitamin/mineral supplements. Furthermore, over half of the CP B/C patients consumed ONS and they also ate more snacks/day than CP-A patients. The high intake of ONS is likely a marker of the challenges these patients face with more traditional food intake. The majority of patients ate foods from each of the four food groups, with the exception of lower daily meat intake in patients with CP-B/C disease. The latter finding is in accordance with previously reported data  and with findings from our local data in 630 liver transplant listed patients with cirrhosis, where we demonstrated that only 24% of patients met protein intake targets.
The barriers to nutritional intake were not surprisingly more common in patients with advanced cirrhosis. Symptoms such as poor appetite, nausea, pain, ascites control, and altered taste represent potential challenges to meeting nutritional targets. In a cohort of patients with Hepatitis C, Musialik et al. demonstrated that umami and salty tastes were impaired when compared to a healthy population, whereas sweet flavor perception was heightened. Because umami is most associated with the palatability of proteins, the progressive derangement of umami sensitivity in patients with worsening liver disease becomes a possible explanation for decreased protein intake. The finances to buy food were surprisingly reported as being adequate in most of our patients with cirrhosis, but shopping and meal preparation were recognized as being more common barriers to nutritional intake in patients with CP-B/C disease and in patients who were unmarried.
How can we use the nutritional information gathered in this study to inform change in practice? In our experience, the routine involvement of a dietician has been an essential enabler of improved education and nutritional intake, both of which are less likely to happen in a busy solo hepatologist clinic. The current study has identified significant and potentially modifiable barriers to intake, particularly in patients with more advanced dysfunction but to our surprise even in patients with early stage cirrhosis. We would propose that nutritional intake patterns and barriers be routinely addressed at clinic visits (see [Table 5] for potential clinic encounter questions). If the palatability of animal-based protein is noted to be an issue, vegetarian protein alternatives (legumes, dairy) to achieving targets can be provided. ONS should be liberally recommended, particularly as a late-evening snack in patients with more advanced liver dysfunction. Socioeconomic status and certain factors such as education, occupational class, and household income have been clearly linked with healthy food choices in other studies. Because these are potentially modifiable with social work support, our data would support directed questioning about shopping and meal preparation, particularly for patients with more advanced disease and for those without a spouse.
|Table 5: Examples of screening questions that can be asked in clinical practice|
Click here to view
Physical activity levels were low in this cohort of patients and are in keeping with the low peak oxygen uptake identified in patients with cirrhosis., The median physical activity level reported in our study cohort [693 (IQR: 1748) MET-minutes/week], much lower than the 1743 MET-minutes/week seen in a cohort of 187 dialysis patients from China, highlights a large and potentially modifiable physical activity deficit. Despite the low physical activity levels, overall EBBS scores were similar to healthy controls, suggesting that perceived barriers and enablers to exercise were similar to patients without chronic disease. Patients in the lowest activity category did have significantly lower EBBS scores than those of their higher activity counterparts, indicating greater perceived barriers and fewer perceived enablers. While many of the barriers investigated by the EBBS did not represent a major deterrent to activity, three statements, “exercise tires me,” “I am fatigued by exercise,” and “exercise is hard work for me” were the most frequently reported barriers to activity at 65%, 61%, and 58% respectively. The same three questions from the EBBS have been previously found to be the most prevalent in persons with physical disabilities or chronic health conditions. Though it is well-known that fatigue poses a particular challenge for patients with chronic liver disease, effective strategies for combating fatigue are less well understood.
What can be done to improve physical activity levels in our patients with cirrhosis? The lack of guidelines related to physical activity in cirrhosis and initial perceptions that exercise may be unsafe in cirrhosis  are an important barrier that make it less likely that physicians will promote it to their patients. The mitigation of this barrier will require further evidence of the benefits of exercise and integration of the existing data into practice guidelines. At a minimum, patients should be asked simple screening questions about physical activity in order to create awareness about the subject [Table 5]. Cardiac rehabilitation programs for coronary artery disease patients have significantly impacted both cardiac and all cause mortality through the combination of exercise programs and patient lifestyle education that focus on enhancing enablers and reducing barriers. It is not too far of a stretch to hypothesize that similar results could be accomplished in the cirrhosis population. Similar to the importance of a dietician, we would propose the routine involvement of an expert in physical therapy would be an ideal component to a well-rounded multidisciplinary cirrhosis care team.
Several limitations of our study require mention. First, the sample size was moderate. Second, there was no healthy control group included in our study. Third, as it has previously been evaluated,,, and as it would have extended the survey duration considerably, we did not collect detailed data on anthropometrics or calorie and protein intake in this population. Consequently, it was not possible to directly examine the relationship between our identified barriers, nutritional status, or quantitative macronutrient intake. Fourth, while the majority of patients had already received dietary counselling by the time they participated in the study, our clinics did not provide routine access to a physical therapist. It is probable that results in a cohort without dietician intervention or with access to a physical therapist would demonstrate different barriers. Fifth, although validated in many studies, when compared to direct measurements of physical activity by objective tools, the IPAQ-SF is biased to overestimate physical activity. In our patient population, where physical activity levels are already very low, direct measurement would have likely led to even lower actual activity levels. Finally, as we chose to include only outpatients with cirrhosis, the results of our analysis cannot be extended to hospitalized patients with cirrhosis. Moreover, given the modest sample size, there would be insufficient power to perform statistical comparisons using three groups (CP-A/B/C).
| Conclusions|| |
To conclude, by evaluating barriers and enablers to lifestyle measures in cirrhosis, this study has addressed steps one and two in the Theoretical Domains Framework for implementing behaviour change. The cirrhosis patient population self-reported quantifiable issues with achieving daily adequate nutrition and exercise levels. Significant barriers remain regarding adoption of nutritional and physical activity interventions in patients with cirrhosis, especially as disease severity worsens but even in compensated patients. A unique feature of this study is that the barriers to nutritional interventions occur despite the patients having regular access to a registered dietician.
Ideally, clinicians should incorporate brief questions regarding a patient's nutritional intake and physical activity practices into their daily clinical encounters with patients [Table 5]. Recognizing that clinic time-limitations prevent detailed nutrition and exercise assessments, we propose that clinicians begin monitoring their patients and creating a dialogue. As nutrition and exercise interventions are assessed for impact on quality of life, symptom burden, transplant wait list, MELD, and longevity, then it will be the health care system's responsibility to instill the necessary changes. In turn, this will shift to a more patient-focused care model by embracing a multidisciplinary chronic disease management approach with access to dietician, physical therapy, and social work resources. Research evaluating lifestyle interventions should consider and integrate possible solutions to overcoming modifiable barriers and enhancing enablers and sensible appreciation of the limitations of pharmacotherapies for some patient populations.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
D'Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986;31:468-75.
Schuppan D, Afdhal NH. Liver cirrhosis. The Lancet 2008;371:838-51.
Jones JC, Coombes JS, Macdonald GA. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl 2012;18:146-51.
Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, et al
. Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value. Liver Transpl 2012;18:1209-16.
Bernal W, Martin-Mateos R, Lipcsey M, Tallis C, Woodsford K, McPhail MJ, et al
. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl 2014;20:54-62.
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793-801.
Cawood AL, Elia M, Stratton RJ. Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Res Rev 2012;11:278-96.
Ney M, Vandermeer B, van Zanten SJ, Ma MM, Gramlich L, Tandon P. Meta-analysis: Oral or enteral nutritional supplementation in cirrhosis. Aliment Pharmacol Ther 2013;37:672-9.
Plank LD, Gane EJ, Peng S, Muthu C, Mathur S, Gillanders L, et al
. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: A randomized 12-month trial. Hepatology 2008;48:557-66.
Manguso F, D'Ambra G, Menchise A, Sollazzo R, D'Agostino L. Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: A prospective study. Clin Nutr 2005;24:751-9.
Zenith L, Meena N, Ramadi A, Yavari M, Harvey A, Carbonneau M, et al
. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol 2014;12:1920-6 e2.
Roman E, Torrades MT, Nadal MJ, Cardenas G, Nieto JC, Vidal S, et al
. Randomized pilot study: Effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci 2014;59:1966-75.
Berzigotti A, Albillos A, Villanueva C, Genesca J, Ardevol A, Augustin S, et al
. Lifestyle intervention by a 16-week programme of supervised diet and physical exercise ameliorates portal hypertension in patients with cirrhosis and obesity: The SportDiet study (Abstract #110). Hepatology 2014;60:253A.
French SD, Green SE, O'Connor DA, McKenzie JE, Francis JJ, Michie S, et al
. Developing theory-informed behaviour change interventions to implement evidence into practice: A systematic approach using the Theoretical Domains Framework. Implement Sci 2012;7:38.
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al
. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-95.
Sechrist KR, Walker SN, Pender NJ. Development and psychometric evaluation of the exercise benefits/barriers scale. Res Nurs Health 1987;10:357-65.
Huisman EJ, Trip EJ, Siersema PD, van Hoek B, van Erpecum KJ. Protein energy malnutrition predicts complications in liver cirrhosis. Eur J Gastroenterol Hepatol 2011;23:982-9.
Ney M, Abraldes JG, Ma M, Belland D, Harvey A, Robbins S, et al
. Insufficient protein intake is associated with increased mortality in 630 patients with cirrhosis awaiting liver transplantation. Nutr Clin Pract 2015;30:530-6.
D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol 2006;44:217-31.
Musialik J, Suchecka W, Klimacka-Nawrot E, Petelenz M, Hartman M, Blonska-Fajfrowska B. Taste and appetite disorders of chronic hepatitis C patients. Eur J Gastroenterol Hepatol 2012;24:1400-5.
Newnham K, Jensen L, Carbonneau M, Tandon P. Adherence to clinical practice guidelines for cirrhosis: Hepatologist care alone compared to a specialty Cirrhosis Care Clinic: University of Alberta; 2015.
Laporte M, Teterina A. Validity and reliability of the new Canadian Nutrition Screening Tool in the 'real-world' hospital setting. Eur J Clin Nutr 2015;69:865.
Lallukka T, Laaksonen M, Rahkonen O, Roos E, Lahelma E. Multiple socio-economic circumstances and healthy food habits. Eur J Clin Nutr 2007;61:701-10.
Li M, Li L, Fan X. Patients having haemodialysis: Physical activity and associated factors. J Adv Nurs 2010;66:1338-45.
Malone LA, Barfield JP, Brasher JD. Perceived benefits and barriers to exercise among persons with physical disabilities or chronic health conditions within action or maintenance stages of exercise. Disabil Health J 2012;5:254-60.
Newton JL, Jones DE. Managing systemic symptoms in chronic liver disease. J Hepatol 2012;56(Suppl 1):S46-55.
Garcia-Pagan JC, Santos C, Barbera JA, Luca A, Roca J, Rodriguez-Roisin R, et al
. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology 1996;111:1300-6.
Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al
. Exercise-based rehabilitation for patients with coronary heart disease: Systematic review and meta-analysis of randomized controlled trials. Am J Med 2004;116:682-92.
Nielsen K, Kondrup J, Martinsen L, Stilling B, Wikman B. Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis. Br J Nutr 1993;69:665-79.
Peng S, Plank LD, McCall JL, Gillanders LK, McIlroy K, Gane EJ. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: A comprehensive study. Am J Clin Nutr 2007;85:1257-66.
Ney M, Abraldes JG, Ma M, Belland D, Harvey A, Robbins S, et al
. Insufficient protein intake is associated with increased mortality in 630 patients with cirrhosis awaiting liver transplantation. Nutr Clin Pract 2015;30:530-6.
Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): A systematic review. Int J Behav Nutr Phys Act 2011;8:115.
Volk ML, Piette JD, Singal AS, Lok AS. Chronic disease management for patients with cirrhosis. Gastroenterology 2010;139:14-6 e1.
Faulkner G, Cohn T, Remington G. Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophr Res 2006;82:225-31.
Scheeres K, Knoop H, Meer V, Bleijenberg G. Clinical assessment of the physical activity pattern of chronic fatigue syndrome patients: A validation of three methods. Health Qual Life Outcomes 2009;7:29.
Kaleth AS, Ang DC, Chakr R, Tong Y. Validity and reliability of community health activities model program for seniors and short-form international physical activity questionnaire as physical activity assessment tools in patients with fibromyalgia. Disabil Rehabil 2010;32:353-9.
Committee IR. Guidelines for the data processing and analysis of the International Physical Activity Questionnaire 2005; Available from: www.ipaq.ki.se. [Last accessed on 2015 Mar 30].
Division of Gastroenterology, University of Alberta, 130.University Campus, Edmonton, Alberta
Source of Support: None, Conflict of Interest: None
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]
| Article Access Statistics|
| Viewed||1993 |
| Printed||25 |
| Emailed||0 |
| PDF Downloaded||538 |
| Comments ||[Add] |